CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(05): 347-350
Placenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
1
Department of Gynecology and Obstetrics, Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
2
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, United Kingdom
,
3
Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom
,
1
Department of Gynecology and Obstetrics, Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
2
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, United Kingdom
,
2
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, United Kingdom
3
Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom
› Author Affiliations
References
1 Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Dec 15]. Available from: https://www.who.int/reproductivehealth/publications/maternal-mortality-2000-2017/en/
2
Jauniaux E,
Bunce C,
Grønbeck L,
Langhoff-Roos J.
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol 2019; 221 (03) 208-218
3
Morlando M,
Sarno L,
Napolitano R,
Capone A,
Tessitore G,
Maruotti GM.
et al.
Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand 2013; 92 (04) 457-460
4
Higgins MF,
Monteith C,
Foley M,
O'Herlihy C.
Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol 2013; 171 (01) 54-56
5
Cheng KK,
Lee MM.
Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J 2015; 21 (06) 511-517
6
Buca D,
Liberati M,
Calì G,
Forlani F,
Caisutti C,
Flacco ME.
et al.
Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52 (03) 304-309
7
Pagani G,
Cali G,
Acharya G,
Trisch IT,
Palacios-Jaraquemada J,
Familiari A.
et al.
Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97 (01) 25-37
8
Melcer Y,
Jauniaux E,
Maymon S,
Tsviban A,
Pekar-Zlotin M,
Betser M.
et al.
Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 2018; 218 (04) 443.e1-443.e8
9
Fitzpatrick KE,
Sellers S,
Spark P,
Kurinczuk JJ,
Brocklehurst P,
Knight M.
The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG 2014; 121 (01) 62-70 , discussion 70–71
10
Bowman ZS,
Eller AG,
Kennedy AM,
Richards DS,
Winter 3rd TC,
Woodward PJ.
et al.
Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014; 211 (02) 177.e1-177.e7
11
Iacovelli A,
Liberati M,
Khalil A,
Timor-Trisch I,
Leombroni M,
Buca D.
et al.
Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33 (03) 471-481
12
De Mucio B,
Serruya S,
Alemán A,
Castellano G,
Sosa CG.
A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. Int J Gynaecol Obstet 2019; 147 (03) 281-291
13
Fitzpatrick KE,
Sellers S,
Spark P,
Kurinczuk JJ,
Brocklehurst P,
Knight M.
Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012; 7 (12) e52893
14
Garmi G,
Goldman S,
Shalev E,
Salim R.
The effects of decidual injury on the invasion potential of trophoblastic cells. Obstet Gynecol 2011; 117 (01) 55-59
15
Sholapurkar SL.
Increased incidence of placenta praevia and accreta with previous caesareans--a hypothesis for causation. J Obstet Gynaecol 2013; 33 (08) 806-809
16
Tantbirojn P,
Crum CP,
Parast MM.
Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 2008; 29 (07) 639-645
17
Einerson BD,
Comstock J,
Silver RM,
Branch DW,
Woodward PJ,
Kennedy A.
Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion. Obstet Gynecol 2020; 135 (05) 1104-1111
18
Kamel R,
Thilaganathan B.
Time to reconsider elective Cesarean birth. Ultrasound Obstet Gynecol 2021; 57 (03) 363-365
19
Kamara M,
Henderson JJ,
Doherty DA,
Dickinson JE,
Pennell CE.
The risk of placenta accreta following primary elective caesarean delivery: a case-control study. BJOG 2013; 120 (07) 879-886
20
Shi XM,
Wang Y,
Zhang Y,
Wei Y,
Chen L,
Zhao YY.
Effect of primary elective cesarean delivery on placenta accreta: a case-control study. Chin Med J (Engl) 2018; 131 (06) 672-676
21
Kamel R,
Eissa T,
Sharaf M,
Negm S,
Thilaganathan B.
Position and integrity of uterine scar are determined by degree of cervical dilatation at time of Cesarean section. Ultrasound Obstet Gynecol 2021; 57 (03) 466-470
22
D'Antonio F,
Timor-Tritsch IE,
Palacios-Jaraquemada J,
Monteagudo A,
Buca D,
Forlani F.
et al.
First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51 (02) 176-183
23
Panaiotova J,
Tokunaka M,
Krajewska K,
Zosmer N,
Nicolaides KH.
Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol 2019; 53 (01) 101-106
24
Calì G,
Timor-Tritsch IE,
Palacios-Jaraquemada J,
Monteaugudo A,
Buca D,
Forlani F.
et al.
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51 (02) 169-175
25
Kaelin Agten A,
Cali G,
Monteagudo A,
Oviedo J,
Ramos J,
Timor-Tritsch I.
The clinical outcome of cesarean scar pregnancies implanted “on the scar” versus “in the niche”. Am J Obstet Gynecol 2017; 216 (05) 510.e1-510.e6
26
Calí G,
Timor-Tritsch IE,
Forlani F,
Palacios-Jaraquemada J,
Monteagudo A,
Agten AK.
et al.
Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol 2020; 55 (04) 450-459
27
Coutinho CM,
Giorgione V,
Noel L,
Liu B,
Chandraharan E,
Pryce J.
et al.
Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery. Ultrasound Obstet Gynecol 2021; 57 (01) 91-96
28
Jauniaux E,
Ayres-de-Campos D,
Langhoff-Roos J,
Fox KA,
Collins S.
FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel.
FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24
29
Chandraharan E,
Hartopp R,
Thilaganathan B,
Coutinho CM.
How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders?. Best Pract Res Clin Obstet Gynaecol 2021; 72: 92-101
